MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with A

Ambrisentan

Ambrisentan 2.5mg tablets

No stability information

Stability notes for Ambrisentan 2.5mg tablets

There are no stability notes for this medicine.

Supplier

Volibris 2.5mg tablets (GlaxoSmithKline UK Ltd)

Ambrisentan 5mg tablets

Compatible

Stability notes for Ambrisentan 5mg tablets

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the product Volibris 5 mg film coated tablets (GlaxoSmithKline UK) and  Ambrisentan 5mg film-coated Tablets (Cipla EU Ltd).

Suppliers (4) of Ambrisentan 5mg tablets
Ambrisentan 5mg tablets (Accord-UK Ltd)
Ambrisentan 5mg tablets (Cipla EU Ltd)
Ambrisentan 5mg tablets (Viatris UK Healthcare Ltd)
Volibris 5mg tablets (GlaxoSmithKline UK Ltd)

Ambrisentan 10mg tablets

Compatible

Stability notes for Ambrisentan 10mg tablets

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the product Volibris 10mg film coated tablets (GlaxoSmithKline UK) and  Ambrisentan 10mg film-coated Tablets (Cipla EU Ltd).

Suppliers (4) of Ambrisentan 10mg tablets
Ambrisentan 10mg tablets (Accord-UK Ltd)
Ambrisentan 10mg tablets (Cipla EU Ltd)
Ambrisentan 10mg tablets (Viatris UK Healthcare Ltd)
Volibris 10mg tablets (GlaxoSmithKline UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.